Showing results (81-90 of 247) with videos related to
Sort By:
Pageof 25
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|February 24, 2001
Adenoviral p53 gene therapy promotes heat-induced apoptosis in a nasopharyngeal carcinoma cell lineV Qi, L Weinrib, N Ma, et al.Microsurgery|January 1, 1987
New method for cardiac transplantationY Umeki, H P Weinrib, C A MacLeod, et al.Circulation|June 3, 2004
Impact of amoxicillin prophylaxis on the incidence, nature, and duration of bacteremia in children after intubation and dental proceduresPeter B Lockhart, Michael T Brennan, M Louise Kent, et al.Neurology|December 22, 1999
Bradykinin B1 receptor expression and function on T lymphocytes in active multiple sclerosisA Prat, L Weinrib, B Becher, et al.The New Phytologist|October 28, 2020
Understanding and predicting forest mortality in the western United States using long-term forest inventory data and modeled hydraulic damageMartin D Venturas, Henry N Todd, Anna T Trugman, et al.Journal of Pharmaceutical Sciences|November 1, 1979
Urinary iodine excretion rates following intrathecal injections of iodinated organic carbonatesA E Staubus, B N Newton, L C Klein, et al.Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 11, 2021
Basal Insulin Degludec and Glycemic Control Compared to Aspart Via Insulin Pump in Type 1 Diabetes (BIGLEAP): A Single-Center, Open-Label, Randomized, Crossover TrialWendy S Lane, Stephen L Weinrib, Michael J Lawrence, et al.Nano Letters|May 8, 2008
Ultrafast electron and hole dynamics in germanium nanowiresR P Prasankumar, S Choi, S A Trugman, et al.Proceedings of the National Academy of Sciences of the United States of America|April 2, 2020
Trait velocities reveal that mortality has driven widespread coordinated shifts in forest hydraulic trait compositionAnna T Trugman, Leander D L Anderegg, John D Shaw, et al.Headache|October 24, 2023
Evaluating therapeutic benefits of ubrogepant via latent class models: A post hoc exploratory analysis of the ACHIEVE I and ACHIEVE II trialsCharlie J Iaconangelo, Daniel Serrano, Aubrey Manack Adams, et al.Pageof 25